PROTHROMBIN ACTIVATION FRAGMENT (F1.2) IS INCREASED IN PREGNANT PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES.
- 1 February 1997
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 85 (3) , 177-183
- https://doi.org/10.1016/s0049-3848(97)00002-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Immunobiology and Obstetrical Consequences of Antiphospholipid AntibodiesObstetrical & Gynecological Survey, 1994
- Induction of thromboses within renal grafts by high-dose prophylactic OKT3The Lancet, 1992
- Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1+2 measurementsThrombosis Research, 1991
- Assessment of hypercoagulable states by measurement of activation fragments and peptidesBlood Reviews, 1990
- Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activationThe American Journal of Medicine, 1989
- Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.Journal of Clinical Investigation, 1985
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 1981
- Low functional and high antigenic antithrombin iii level in a patient with the lupus anticoagulant and recurrent thrombosisArthritis & Rheumatism, 1981
- Blood CoagulationAnnual Review of Biochemistry, 1980